May 2, 2023 03:27 PM EDT
Pharma
Law

US gov­ern­men­t's court bat­tle be­gins over Gilead HIV drug patents

Katherine Lewin

News Reporter

Ju­ry se­lec­tion be­gins to­day in a Delaware fed­er­al court for the law­suit that kicked off in 2019 when the fed­er­al gov­ern­ment sued Gilead, al­leg­ing that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bi­cy­cle Ther­a­peu­tics stock sinks fol­low­ing re­lease of topline da­ta, post-hoc analy­ses

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

Ab­b­Vie makes an­oth­er small I&I ac­qui­si­tion, buy­ing Nim­ble for $200M

Gilead names Di­et­mar Berg­er CMO as it eyes R&D re­set

Xaira hires for­mer Roche ex­ec as CMO; 'Tis the sea­son for re­tire­ments at Al­ny­lam, Re­gen­eron

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times